Startup Diligence
Latest private-market research

Startup diligence,
written by AI.

Each report runs end-to-end research on a private startup and writes it up like an investment committee memo: cover snapshot, executive summary, market sizing, competitors, financials, product, customers, risks, and valuation. Every claim links to a public source.

Latest reports

Newest generated reports first. Top-rated rankings live on their own page.

View archive
Mobility finance and autonomous-fleet operations Late-stage private; Series C

Moove

Moove has reported substantial operating scale and a $2.1 billion Series C valuation, but unverified earnings, capital needs, and partner exposure make investment approval premature.

Research more Unknown Risk: High
Valuation
$2.1B
ARR
$420M
public safety software private

Mark43

Mark43 has meaningful public-sector reach and a broad mission-critical platform, but undisclosed economics, ambiguous customer metrics, and unpriced acquisition terms leave valuation and returns ununderwritable.

Research more Unknown Risk: High
Healthcare / Biotechnology — Antibody-Drug Conjugates Public, clinical-stage

LigaChem Biosciences

LigaChem’s partnered ADC platform and selective in-house clinical progress offer meaningful optionality, but losses, uncertain cash runway, contingent deal economics, and the absence of a defensible current valuation support research-more rather than a high-conviction entry.

Research more Unknown Risk: High
Healthcare / Biotech Clinical-stage private

LifeMine Therapeutics

LifeMine's 2026 financing and ongoing Phase 1 program merit tracking, but undisclosed transaction terms, liquidity, and independent clinical outcomes leave valuation and entry price unassessable.

Track Unknown Risk: High
fintech / BNPL / digital credit / digital banking late-stage private

Kredivo

Kredivo combines established digital-credit scale and banking optionality, but missing parent economics, credit cohorts, and a current entry price support further diligence rather than an investment commitment.

Research more Unknown Risk: High
Procurement software / spend management Private; Hg acquisition reported in 2024

Ivalua

Ivalua has a credible, broad enterprise source-to-pay platform, but undisclosed current economics, transaction terms, and governance prevent a high-conviction valuation call; further diligence is warranted.

Research more Unknown Risk: High
Decentralized identity / biometrics / blockchain Private company; token-network project

Humanity Protocol

Humanity Protocol has product activity and identity-market optionality, but the 2026 key compromise, unproven commercial conversion, and absent current financial disclosure keep the recommendation at research-more.

Research more Unknown Risk: High
insurance telematics / mobility AI growth-stage private company

Cambridge Mobile Telematics

CMT has a scaled telematics platform and strategic validation, but opaque economics and an unverified cyber allegation support further diligence rather than an entry decision.

Research more Unknown Risk: High
AI infrastructure / AI-factory development Private; Seed and Series A disclosed

Volta

Volta's financing-led AI-factory model is differentiated, but public evidence supports research-more discipline rather than underwriting its reported $2.4 billion valuation.

Research more Stretched Risk: High
Valuation
$2.4B
battery manufacturing / energy storage Private; current financing stage undisclosed

Our Next Energy (ONE)

ONE's LFP platform and customer activity support continued diligence, but delivery conversion, current unit economics, financing terms, and liquidity remain unverified.

Research more Unknown Risk: High
fintech Series C, late-stage private

Moss

Moss has reported late-stage scale and an integrated finance workflow, but conflicting financing disclosures and unverified unit economics, retention, and capital terms leave the €1.0bn mark too difficult to underwrite for a buy.

Track Stretched Risk: High
Consumer / food & beverage / specialty coffee Late-stage private company

Manner Coffee

Reported scale and a compact, value-oriented format merit continued diligence, but financial opacity, execution risks, and the absence of a verified current valuation preclude an investment call.

Research more Unknown Risk: High

Showing 12 of 1,437 reports.

See all 1,437 reports →